<div id="readability-page-1"><div><p><span>Pereira Brian J G, Director of ProKidney Corp [PROK], filed a Form 144 on November 12, 2025 with the Securities and Exchange Commission proposing to sell restricted securities:</span></p><div><table><tbody><tr><td><span>Approximate Date Of Sale</span></td><td><span>11/12/25</span></td></tr><tr><td><span>Shares</span></td><td><span>675,234</span></td></tr><tr><td><span>Broker</span></td><td><span>Merrill Lynch Pierce Fenner &amp; Smith Inc</span></td></tr></tbody></table></div><p><span>Prior to the sale of restricted stock, owners must file a Form 144 with the SEC.  Upon submission of the filing to the SEC the owner is permitted to sell the shares, or any fraction thereof, within 90 days.</span></p><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

PROK

<p>Brian J G Pereira, Director of ProKidney Corp [PROK], has filed a Form 144 with the SEC on November 12, 2025, to sell 675,234 shares of restricted securities through Merrill Lynch. The filing allows him to sell the shares within 90 days of submission.</p>

Dir Pereira Files To Sell 675,234 Of ProKidney Corp [PROK]